113 results
8-K
EX-99.1
NDRA
ENDRA Life Sciences Inc
14 May 24
ENDRA Life Sciences Reports First Quarter 2024 Financial Results and Provides a Business Update
4:17pm
, beginning of period
Cash, end of period
Supplemental disclosures of cash items
Interest paid
Income tax paid
Supplemental disclosures of non-cash items
Stock dividend payable
Right of use asset
Lease liability
# # #
424B5
ryascg88963fp0i69
3 Apr 24
Prospectus supplement for primary offering
5:14pm